Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 31 Melanoma 20 Neoplasms 13 Breast Neoplasms 11 Pancreatic Neoplasms 9 Lung Neoplasms 9 Head and Neck Neoplasms 9 Triple Negative Breast Neoplasms 8 Stomach Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Ovarian Neoplasms 8 Neoplasm Metastasis 8 Colorectal Neoplasms 7 Carcinoma, Renal Cell 7 Carcinoma, Hepatocellular 6 Prostatic Neoplasms 4 Hodgkin Disease 4 Glioblastoma 4 Carcinoma, Transitional Cell 4 Carcinoma 4 Uterine Cervical Neoplasms 3 Liver Neoplasms 3 Kidney Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Esophageal Neoplasms 3 Adenocarcinoma 3 Small Cell Lung Carcinoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms, Squamous Cell 2 Mesothelioma 2

Interventions

talimogene laherparepvec 1 pembrolizumab 1 daromun 1 Vincristine 1 Therapeutics 1 Psychiatric Rehabilitation 1 Liposomes 1 Doxorubicin 1 Diagnostic Tests, Routine 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Sarcoma, Kaposi × pembrolizumab × Clear all

NCT03469804 2019-10-21

KAPKEY

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Sarcoma, Kaposi, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡